2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 7 USDMF, 2 CEP/COS, 1 JDMF, 2 EU WC, 4 NDC API, 15 Listed Suppliers, $ API Reference Price

20 API Suppliers
7 USDMF
2 CEP/COS
1 JDMF
2 EU WC
4 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

39 FDF Dossiers, 7 FDA Orange Book, 12 Europe, 1 Canada, 6 Australia, 2 South Africa, 11 Listed Dossiers

39 FDF Dossiers
7 FDA Orange Book
12 Europe
1 Canada
6 Australia
2 South Africa
11 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 7 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 3 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 13 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 27 Direct Compression, 16 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 15 Granulation, 12 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 11 Parenteral, 11 Taste Masking, 10 Lubricants & Glidants, 10 Coating Systems & Additives, 10 Solubilizers, 8 Controlled & Modified Release, 8 Empty Capsules, 4 Film Formers & Plasticizers, 3 Coloring Agents, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 API Stability Enhancers

50 Fillers, Diluents & Binders
27 Direct Compression
16 Thickeners and Stabilizers
16 Disintegrants & Superdisintegrants
15 Granulation
12 Co-Processed Excipients
11 Chewable & Orodispersible Aids
11 Parenteral
11 Taste Masking
10 Lubricants & Glidants
10 Coating Systems & Additives
10 Solubilizers
8 Controlled & Modified Release
8 Empty Capsules
4 Film Formers & Plasticizers
3 Coloring Agents
2 Rheology Modifiers
2 Emulsifying Agents
1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 8 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices, 3 Annual Reports

1 US Medicaid Prescriptions
6 Finished Drug Prices
3 Annual Reports

MARKET PLACE

8 APIs, 3 FDF Dossiers

8 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 4 Others

2 EDQM
3 USP
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,792 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1EXELA PHARMA

filter Patent Number Reset all filters

1 All

01 19486530

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12034-09-02

Product Main Page

01

EXELA PHARMA

2024 ACI Convention

Not Confirmed

EXELA PHARMA

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-09-02

GANCICLOVIR

US Patent Number : 9486530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209347

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-09-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?